This alteration occurs independently of metabolic control, considering that no significant differences in HbA1c were demonstrated in the present setting; although it was achieved with different pharmacologic treatments, the level of glycated albumin was moderately increased in DKD patients. The gene discussed is ALB; the disease is diabetic kidney disease.